IQV earnings date and last-quarter result: last quarter beat, P/E 24.39. Updated 2026-07-23.
IQVIA Holdings (IQV) Research Hub
IQVIA Holdings (IQV) trades on NYSE, US in the Healthcare (Medical - Diagnostics & Research) sector. As of 2026-10-26, shares last closed at 273.6 USD (-2.06%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 24.39, market cap 33.51B. This hub links to the full technical, earnings and options research available for IQV.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Diagnostics & Research) |
|---|---|
| Exchange | NYSE, US |
| Last close | 273.6 USD (-2.06%) |
| 52-week range | 163.35 USD – 282.98 USD |
| Trend regime | Range |
| 14-day RSI | 66.1 (Bullish) |
| Trailing P/E | 24.39 |
| Market cap | 33.51B |
| Dividend yield | 0.00% |
Available research for IQV
Covered Call on IQV: how it works, illustrative setup around the real 273.6 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on IQV: how it works, illustrative setup around the real 273.6 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on IQV: how it works, illustrative setup around the real 273.6 USD price, max profit/loss, breakeven and when to use it. Educational.
IQV technical analysis: range, last 273.6 USD, RSI 66.1, 52w range 163.35 USD–282.98 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is IQV in?
IQVIA Holdings (IQV) is classified under Healthcare (Medical - Diagnostics & Research), listed on NYSE, US.
Is IQV in an uptrend or downtrend?
As of 2026-10-26, IQV is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is IQV's trailing P/E ratio?
IQV's trailing P/E is 24.39, with a market cap of 33.51B. See the earnings research page for full valuation detail.